Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 StudyHoward Hochster, Edie Weller, Randy D Gascoyne, et al.
Blood|October 18, 2003
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigensRoberto Bellucci, Catherine J Wu, Sabina Chiaretti, et al.
Sleep|April 8, 2020
Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1Kiran Maski, Fabio Pizza, Shanshan Liu, et al.
Blood|May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myelomaRoberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or youngerAndrea K Ng, M Patricia Bernardo, Edie Weller, et al.
Blood|August 30, 2002
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cellsDharminder Chauhan, Laurence Catley, Teru Hideshima, et al.
Blood|October 28, 2006
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosisRoberto Bellucci, Sabine Oertelt, Meagan Gallagher, et al.
Blood|February 5, 2005
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorRoberto Bellucci, Edwin P Alyea, Sabina Chiaretti, et al.
Blood|August 30, 2002
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsAndrea K Ng, M V Patricia Bernardo, Edie Weller, et al.
Leukemia & Lymphoma|November 25, 2011
Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493)Peter H Wiernik, Hailun Li, Edie Weller, et al.
Pageof 8